Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue:    
Total revenue $ 36,971 $ 31,390
Cost of revenue 14,279 12,268
Gross profit 22,692 19,122
Research and development costs 13,897 12,392
Sales and marketing expenses 16,461 14,478
General and administrative expenses 16,498 11,986
Operating loss (24,164) (19,734)
Other income (expense):    
Other expense, net (146) (40)
Interest income 1,213 1,390
Interest expense (2,388) (518)
Net loss before income taxes (25,485) (18,902)
Income tax expense 55 12
Net loss $ (25,540) $ (18,914)
Net loss per share attributable to common stockholders:    
Basic (in dollars per share) $ (0.9) $ (0.7)
Diluted (in dollars per share) $ (0.9) $ (0.7)
Weighted average shares outstanding:    
Basic (in shares) 28,315,254 27,027,692
Diluted (in shares) 28,315,254 27,027,692
Product revenue    
Revenue:    
Total revenue $ 23,859 $ 18,626
Service and other revenue    
Revenue:    
Total revenue $ 13,112 $ 12,764